(Q74844446)
Statements
Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases (English)
K Nozawa
J Ohata
J Sakurai
H Hashimoto
H Miyajima
H Yagita
K Okumura
1 November 2001